The Magazine for Sleep Professionals
Friday, August 28, 2026
Obstructive sleep apnea (OSA) is a complex condition with a variety of contributing anatomical, physiological, inflammatory, and obesity-related risk factors, which can lead to many physiological changes in the body.1 Yet for patients with OSA, there is good reason to be hopeful right now. We are witnessing tremendous advances in […]
As a board-certified sleep physician, I have witnessed firsthand the transformative impact of artificial intelligence (AI) and machine learning (ML) in the field of sleep medicine. Their integration in both polysomnography (PSG) and home sleep testing (HST) has revolutionized the diagnosis and management of sleep disorders. In this article, we’ll […]
Inspire Medical Systems, Inc. announced that two leading physicians in sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire as Vice President and senior Medical Director, effective April 21 and June 2, respectively. “Dr. […]
Depression is more common in people with narcolepsy.1 According to research, around 20 percent of people diagnosed with narcolepsy also experience depression, with some estimates suggesting the prevalence could be as high as 57 percent.1,2 It’s unknown if depression is a primary feature of narcolepsy, or if life is just […]
Beacon Biosignals announced that it has acquired Cleveland Medical Devices Inc. (known as CleveMed), a leader in home sleep testing (HST) technology and services, in a strategic transaction that will strengthen both companies’ capabilities. Jacob Donoghue, MD, PhD, CEO and co-founder of Beacon Biosignals, commented, “There is a lot we […]
Nightmares are not just a fleeting inconvenience—they can have profound implications on mental health and overall well-being. Recent studies have suggested that nightmares are underdiagnosed and undertreated, even in sleep centers.1,2 Because it is unlikely that patients will report nightmares without provocation, it is important for providers to inquire about […]
Sleep apnea is a growing health concern in the United States, affecting approximately 54 million Americans, with 80% of cases remaining undiagnosed. This widespread issue continues to contribute to serious health problems, including cardiovascular disease, stroke, diabetes, and depression. As the U.S. population ages and the obesity epidemic persists, the […]
Persante Health Care has acquired Sleep Management Services (SMS), a business process outsourcing company specializing in sleep care services across Arkansas and Texas. Funding for the acquisition was provided by Peninsula Capital Partners, a Detroit-based private investment firm that has raised and invested over $2 billion in capital across eight […]
EnsoData, an innovator in AI healthtech solutions, is enhancing the FDA-cleared EnsoSleep PPG home sleep apnea testing (HSAT) solution by integrating three new physical channels. These channels provide additional physiological data to support sleep clinicians in diagnosing and treating sleep disorders using FDA-cleared pulse oximeters. EnsoData introduces all three channels […]
Nyxoah SA, which develops breakthrough treatment alternatives for obstructive sleep apnea (OSA) through neuromodulation, announced an update on the FDA approval process for the Genio system. On March 26, 2025, the Company announced that the U.S. Food and Drug Administration (FDA) issued an Approvable Letter regarding the Company’s Pre-Market Approval […]
